NeOnc gets UAE approval for NEO100 brain cancer drug trials
NeOnc Technologies Holdings (Nasdaq: NTHI) announced that the Department of Health – Abu Dhabi has granted Investigational New Drug status ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
